SOLUBLE CD4 AND CD8 MOLECULES IN PATIENTS WITH SYSTEMIC-SCLEROSIS

被引:1
|
作者
TOKANO, Y
KANEKO, H
OBARA, T
HASHIMOTO, H
OKUMURA, K
HIROSE, S
机构
[1] Division of Rheumatology, Department of Internal Medicine and Immunology, Juntendo University, School of Medicine, Tokyo, 113, 2-1-1, Hongo, Bunkyo-ku
[2] Yamanouchi Pharmaceutical Co. Ltd, Tokyo, 117, 1-1-8, Ozusawa. Itabashi-ku
关键词
SOLUBLE CD4; SOLUBLE CD8; SYSTEMIC SCLEROSIS;
D O I
10.1007/BF02231777
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentrations of sCD4 and sCD8 in 69 patients with systemic sclerosis (SSc) were examined by using a sandwich enzyme-linked immunosorbent assay. The patients with SSc had significantly higher concentrations of sCD8 (mean 249.2 U/ml (SD 155.1), median 224 U/ml) than the normal subjects (mean 149.3 U/ml (SD 42.1), median 148 U/ml). The concentration of sCD4 in patients with SSc were significantly lower (mean 6.2 U/ml (SD 3.8), median 5.0 U/ml) than in the normal subjects (mean 10.9 U/ml (SD 4.1), median 10.3 U/ml). The concentration of sCD8 in patients with diffuse sclerosis tended to be higher than in those with sclerodactyly.
引用
收藏
页码:490 / 493
页数:4
相关论文
共 50 条
  • [1] SOLUBLE CD8 ANTIGEN IN SYSTEMIC-SCLEROSIS
    FAMULARO, G
    GIACOMELLI, R
    SACCHETTI, S
    DANESE, C
    LUCIANI, AM
    PEREGO, MA
    TONIETTI, G
    JOURNAL OF CLINICAL & LABORATORY IMMUNOLOGY, 1990, 32 (03) : 109 - 112
  • [2] SOLUBLE CD4/CD8 MOLECULES IN RHEUMATIC DISORDERS
    SAWADA, S
    TAKEI, M
    MITAMURA, K
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 72 (02): : 177 - 180
  • [3] SOLUBLE CD4, CD8 IN PATIENTS WITH POLYMYOSITIS DERMATOMYOSITIS
    TOKANO, Y
    OBARA, T
    HASHIMOTO, H
    OKUMURA, K
    HIROSE, S
    CLINICAL RHEUMATOLOGY, 1993, 12 (03) : 368 - 374
  • [4] INCREASED SOLUBLE CD4 AND DECREASED SOLUBLE CD8 MOLECULES IN PATIENTS WITH SJOGRENS-SYNDROME
    SAWADA, S
    SUGAI, S
    IIJIMA, S
    TAKEI, M
    PAREDES, E
    HAYAMA, T
    NISHINARITA, S
    HOSOKAWA, Y
    HORIE, T
    OBARA, T
    AMERICAN JOURNAL OF MEDICINE, 1992, 92 (02): : 134 - 140
  • [5] IMMUNOLOGICAL SIGNIFICANCE OF INCREASED SOLUBLE CD8/CD4 MOLECULES IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS-ERYTHEMATOSUS
    SAWADA, S
    HASHIMOTO, H
    IIJIMA, S
    TOKANO, Y
    TAKEI, M
    SHIDA, M
    OBARA, T
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1993, 7 (03) : 141 - 146
  • [6] SOLUBLE CD4, CD8, AND HLA MOLECULES IN COMMERCIAL IMMUNOGLOBULIN PREPARATIONS
    BLASCZYK, R
    WESTHOFF, U
    GROSSEWILDE, H
    LANCET, 1993, 341 (8848): : 789 - 790
  • [7] MITOGEN STIMULATED LYMPHOCYTES-T IN SYSTEMIC-SCLEROSIS (SSC) - CORRELATION WITH SOLUBLE CD4, CD8, AND INTERLEUKIN-2 RECEPTOR
    ALLEGAR, NE
    LI, XL
    TUDOR, A
    SEIBOLD, JR
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S237 - S237
  • [8] Soluble CD4 and CD8 in serum from patients with localized scleroderma
    Sato, S
    Fujimoto, M
    Kikuchi, K
    Ihn, H
    Tamaki, K
    Takehara, K
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1996, 288 (07) : 358 - 362
  • [9] DIFFERENTIAL SIGNALING VIA CD4 AND CD8 MOLECULES
    RAVICHANDRAN, KS
    HOLLANDER, GA
    BURAKOFF, SJ
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A265 - A265
  • [10] REDUCED CD4 AND CD8 EXPRESSION IN HUMAN THYMUSES TREATED WITH SOLUBLE CD4
    ZEPP, F
    EHLERT, K
    OTHMER, M
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 34 (02) : 185 - 195